Trial intelligence / Profile preview

Alpha-lipoic Acid for Paclitaxel-Induced Neuropathy

NCT01313117Phase 2Completed

Sponsor
Northwestern University
Start
Feb 2012
Primary completion
Aug 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of alpha-lipoic acid in peripheral neuropathy, sponsored by Northwestern University. Started Feb 2012; status: completed.

02

Drugs

alpha-lipoic acid
03

Conditions

peripheral neuropathy

Beyond the preview

Go deeper on NCT01313117.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01313117.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call